JP2024537398A5 - - Google Patents

Info

Publication number
JP2024537398A5
JP2024537398A5 JP2024522502A JP2024522502A JP2024537398A5 JP 2024537398 A5 JP2024537398 A5 JP 2024537398A5 JP 2024522502 A JP2024522502 A JP 2024522502A JP 2024522502 A JP2024522502 A JP 2024522502A JP 2024537398 A5 JP2024537398 A5 JP 2024537398A5
Authority
JP
Japan
Prior art keywords
self
polypeptide complex
complex according
assembling polypeptide
mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024522502A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024537398A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2022/051517 external-priority patent/WO2023060359A1/en
Publication of JP2024537398A publication Critical patent/JP2024537398A/ja
Publication of JP2024537398A5 publication Critical patent/JP2024537398A5/ja
Pending legal-status Critical Current

Links

JP2024522502A 2021-10-16 2022-10-14 ＳＡＲＳ－ＣｏＶ－２を標的とする改変されたＭｕｌｔａｂｏｄｙ構築物、組成物、及び方法 Pending JP2024537398A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163256565P 2021-10-16 2021-10-16
US63/256,565 2021-10-16
PCT/CA2022/051517 WO2023060359A1 (en) 2021-10-16 2022-10-14 Modified multabody constructs, compositions, and methods targeting sars-cov-2

Publications (2)

Publication Number Publication Date
JP2024537398A JP2024537398A (ja) 2024-10-10
JP2024537398A5 true JP2024537398A5 (https=) 2025-10-22

Family

ID=85987097

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024522502A Pending JP2024537398A (ja) 2021-10-16 2022-10-14 ＳＡＲＳ－ＣｏＶ－２を標的とする改変されたＭｕｌｔａｂｏｄｙ構築物、組成物、及び方法

Country Status (5)

Country Link
US (1) US20250011397A1 (https=)
EP (1) EP4416189A4 (https=)
JP (1) JP2024537398A (https=)
CA (1) CA3235530A1 (https=)
WO (1) WO2023060359A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874239A (en) 1993-07-30 1999-02-23 Affymax Technologies N.V. Biotinylation of proteins
DE10113776B4 (de) 2001-03-21 2012-08-09 "Iba Gmbh" Isoliertes streptavidinbindendes, kompetitiv eluierbares Peptid, dieses umfassendes Fusionspeptid, dafür codierende Nukleinsäure, Expressionsvektor, Verfahren zur Herstellung eines rekombinanten Fusionsproteins und Verfahren zum Nachweis und/oder zur Gewinnung des Fusionsproteins
EP1452601A1 (en) 2003-02-28 2004-09-01 Roche Diagnostics GmbH Enhanced expression of fusion polypeptides with a biotinylation tag
AU2020320459A1 (en) * 2019-08-01 2022-03-03 The Governing Council Of The University Of Toronto Multi-valent and multi-specific nanoparticle platforms and methods
CN117157328A (zh) * 2021-01-28 2023-12-01 儿童医院 Multabody构建体、组合物和方法

Similar Documents

Publication Publication Date Title
CN103068846B9 (zh) 包含二硫键稳定性Fv片段的双特异性抗体
JP2020196744A5 (https=)
JP2020180158A5 (https=)
JP2020531438A5 (ja) Ｎｋｇ２ｄ、ｃｄ１６、およびｈｌａ−ｅに結合するタンパク質
JP2019533441A5 (https=)
JP2022512234A5 (https=)
JP2023548045A5 (https=)
IL272747B2 (en) Bispecific antibodies 1 + 2
JP2021533779A5 (https=)
JP2023509212A5 (https=)
RU2016133346A (ru) Варианты fc-области с модифицированной способностью связываться с fcrn и с сохраненной способностью связываться с белком а
JP2022545647A5 (https=)
JP2023554500A5 (https=)
IL292780A (en) A new 4-1bbl trimer containing antigen-binding molecules
RU2019108429A (ru) Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения
JP2021521781A5 (https=)
JP2022549172A5 (https=)
JP2024501539A5 (https=)
JP2020502233A5 (https=)
JP2024532489A5 (https=)
JP2023544211A5 (https=)
JP2023511376A5 (https=)
JP2024504777A5 (https=)
JP2022504826A5 (https=)
JP2021512159A5 (https=)